Anticancer Phenolics from Dryopteris fragrans (L.) Schott
AbstractCancer is one of the most major diseases that threatens human health and life. The aim of this work was to obtain novel anticancer molecules from D. fragrans, a kind of medicinal plant. The structure of the new compound was identified using spectroscopic data (1H-NMR, 13C-NMR and two dimensions NMR). Its anticancer properties were evaluated using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay against four human cells including lung cancer cells (A549), breast cancer cells (MCF-7), gastric cancer cells (SGC7901) and noncancerous human umbilical vein endothelial cells (HUVEC). A new phenylpropanoid—(E)-caffeic acid-9-O-β-d-xylpyranosyl-(1→2)-β-d-glucopyranosyl ester (1), with seven known compounds (2–8)—was isolated. The IC50 value of compound 1 against MCF-7 cells was 2.65 ± 0.14 µM, and the IC50 values of compound 8 against three cancer cells were below 20 µM. View Full-Text
Share & Cite This Article
Liu, Z.-D.; Zhao, D.-D.; Jiang, S.; Xue, B.; Zhang, Y.-L.; Yan, X.-F. Anticancer Phenolics from Dryopteris fragrans (L.) Schott. Molecules 2018, 23, 680.
Liu Z-D, Zhao D-D, Jiang S, Xue B, Zhang Y-L, Yan X-F. Anticancer Phenolics from Dryopteris fragrans (L.) Schott. Molecules. 2018; 23(3):680.Chicago/Turabian Style
Liu, Zhen-Dong; Zhao, Dan-Dan; Jiang, Shuai; Xue, Bei; Zhang, Yan-Long; Yan, Xiu-Feng. 2018. "Anticancer Phenolics from Dryopteris fragrans (L.) Schott." Molecules 23, no. 3: 680.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.